Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | DDX3X | O00571 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14468754 | 0.87 | KMT2A (0.52) | KMT2AMEN1MAPK1NPC1RAB9A | |
| SCHEMBL12782339 | 0.83 | RAB9A (0.60) | KMT2AMEN1MAPK1NPC1RAB9A | |
| SCHEMBL14850288 | 0.79 | GAA (0.71) | KMT2AMEN1MAPK1NPC1RAB9A | |
| SCHEMBL13900226 | 0.78 | MEN1 (0.76) | KMT2AMEN1MAPK1NPC1RAB9A | |
| SCHEMBL4355470 | 0.78 | MEN1 (0.74) | KMT2AMEN1MAPK1NPC1RAB9A | |
| SCHEMBL4345624 | 0.78 | MEN1 (0.56) | KMT2AMEN1MAPK1NPC1RAB9A | |
| SCHEMBL12553579 | 0.77 | HTT (0.45) | KMT2AMEN1MAPK1LMNAHTT | |
| SCHEMBL12360778 | 0.77 | KMT2A (0.42) | KMT2AMEN1MAPK1NPC1RAB9A | |
| SCHEMBL10330603 | 0.76 | KDM4E (0.49) | NPC1RAB9ALMNAMAPTGAA | |
| SCHEMBL12631706 | 0.75 | ALDH1A1 (0.62) | KMT2AMEN1NPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070160635-A1 | Cosmetic composition textured with a specific asymmetric bis-urea derivative | L'OREAL (FR) | 2007-07-12 | — | — | US | disclosed |
| US-20070160635-A1 | Cosmetic composition textured with a specific asymmetric bis-urea derivative | L'OREAL (FR) | 2007-07-12 | — | — | US | disclosed |
| EP-1797864-A1 | Cosmetic composition textured by a specific asymmetric bis-urea derivative | L'OREAL (FR) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070160635-A1 | Cosmetic composition textured with a specific asymmetric bis-urea derivative | FHIT, CUTA, FABP4 | KMT2A 2006/4885MEN1 2781/4885MAPK1 4318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.